NODAL MARGINAL ZONE LYMPHOMA
Clinical trials for NODAL MARGINAL ZONE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new NODAL MARGINAL ZONE LYMPHOMA trials appear
Sign up with your email to follow new studies for NODAL MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered T-Cells take aim at Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new treatment for people with certain types of lymphoma or leukemia that have come back or not responded to standard therapy. The treatment uses the patient's own immune cells, which are modified in a lab to recognize and attack cancer cells. The main goal is t…
Matched conditions: NODAL MARGINAL ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for lymphoma patients: experimental drug epcoritamab enters phase 2 trial
Disease control Recruiting nowThis study tests whether the drug epcoritamab can help people with newly diagnosed marginal zone lymphoma, a type of blood cancer. About 25 adults will receive the treatment to see if it leads to complete remission. The goal is to control the disease, not cure it, as ongoing mana…
Matched conditions: NODAL MARGINAL ZONE LYMPHOMA
Phase: PHASE2 • Sponsor: Izidore Lossos, MD • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug SGR-1505 enters human testing for blood cancers
Disease control Recruiting nowThis early-phase trial tests a new drug, SGR-1505, in about 98 adults with various B-cell blood cancers (like lymphoma or leukemia). The main goals are to check safety, find the best dose, and see how the body handles the drug. Participants must have a confirmed diagnosis and be …
Matched conditions: NODAL MARGINAL ZONE LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated May 04, 2026 16:22 UTC
-
New study aims to unlock secrets of rare lymphoma
Knowledge-focused Recruiting nowThis study looks at tissue samples and medical records from 300 people with nodal marginal zone lymphoma, a rare blood cancer. Researchers want to find genetic patterns that help predict how the disease will behave. The goal is to improve future diagnosis and treatment, but this …
Matched conditions: NODAL MARGINAL ZONE LYMPHOMA
Sponsor: International Extranodal Lymphoma Study Group (IELSG) • Aim: Knowledge-focused
Last updated Apr 26, 2026 19:37 UTC